These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37924456)

  • 1. Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways.
    Meng M; Guo Y; Chen Y; Li X; Zhang B; Xie Z; Liu J; Zhao Z; Liu Y; Zhang T; Qiao Y; Shang B; Zhou Q
    Cell Oncol (Dordr); 2024 Apr; 47(2):657-676. PubMed ID: 37924456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis.
    Shang B; Gao A; Pan Y; Zhang G; Tu J; Zhou Y; Yang P; Cao Z; Wei Q; Ding Y; Zhang J; Zhao Y; Zhou Q
    Cell Death Dis; 2014 Jun; 5(6):e1285. PubMed ID: 24901056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cancer/Testis Antigen CT45A1 Promotes Transcription of Oncogenic
    Yang P; Qiao Y; Liao H; Huang Y; Meng M; Chen Y; Zhou Q
    J Breast Cancer; 2023 Apr; 26(2):168-185. PubMed ID: 37095619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT45A1 promotes the metastasis of osteosarcoma cells in vitro and in vivo through β-catenin.
    Wen M; Ren H; Zhang S; Li T; Zhang J; Ren P
    Cell Death Dis; 2021 Jun; 12(7):650. PubMed ID: 34172717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signaling pathway.
    Tang F; Tang S; Guo X; Yang C; Jia K
    Mol Med Rep; 2017 Nov; 16(5):6708-6714. PubMed ID: 28901509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIMK1 promotes the development of cervical cancer by up-regulating the ROS/Src-FAK/cofilin signaling pathway.
    Jia Y; Li Y; Du N; Zhao W; Liu Y
    Aging (Albany NY); 2024 Jul; 16(13):11090-11102. PubMed ID: 38975937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIP6 accelerates the proliferation and invasion of cervical cancer by upregulating oncogenic YAP signaling.
    Yang F; Li L; Zhang J; Zhang J; Yang L
    Exp Cell Res; 2020 Nov; 396(1):112248. PubMed ID: 32853630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo.
    Zhu K; Deng C; Du P; Liu T; Piao J; Piao Y; Yang M; Chen L
    Reprod Biol Endocrinol; 2022 Mar; 20(1):50. PubMed ID: 35277194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA HOXC-AS3 enhances the progression of cervical cancer via activating ErbB signaling pathway.
    Zhao R; Song J; Jin Y; Liu Y
    J Mol Histol; 2021 Oct; 52(5):991-1006. PubMed ID: 34387789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway.
    Liu T; Liu Y; Bao X; Tian J; Liu Y; Yang X
    PLoS One; 2013; 8(9):e75864. PubMed ID: 24086649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
    Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
    Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00673 exerts oncogenic function in cervical cancer by negatively regulating miR-126-5p expression and activates PTEN/PI3K/AKT signaling pathway.
    Shi WJ; Liu H; Ge YF; Wu D; Tan YJ; Shen YC; Wang H; Xu H
    Cytokine; 2020 Dec; 136():155286. PubMed ID: 32950808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
    Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
    Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary oleic acid-induced CD36 promotes cervical cancer cell growth and metastasis via up-regulation Src/ERK pathway.
    Yang P; Su C; Luo X; Zeng H; Zhao L; Wei L; Zhang X; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
    Cancer Lett; 2018 Dec; 438():76-85. PubMed ID: 30213558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PBK promotes aggressive phenotypes of cervical cancer through ERK/c-Myc signaling pathway.
    Ma H; Han F; Yan X; Qi G; Li Y; Li R; Yan S; Yuan C; Song K; Kong B
    J Cell Physiol; 2021 Apr; 236(4):2767-2781. PubMed ID: 33184870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway.
    Yang J; Zhang X; Liu L; Yang X; Qian Q; Du B
    Life Sci; 2021 Jan; 264():118711. PubMed ID: 33186566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic long intervening noncoding RNA Linc00284 promotes c-Met expression by sponging miR-27a in colorectal cancer.
    You J; Li J; Ke C; Xiao Y; Lu C; Huang F; Mi Y; Xia R; Li Q
    Oncogene; 2021 Jun; 40(24):4151-4166. PubMed ID: 34050266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of phospho-non-receptor Src tyrosine kinases contributes to growth inhibition of cervical cancer cells.
    Kong L; Deng Z; Zhao Y; Wang Y; Sarkar FH; Zhang Y
    Med Oncol; 2011 Dec; 28(4):1495-506. PubMed ID: 20532678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via activating AKT signaling pathway.
    Diao W; Guo Q; Zhu C; Song Y; Feng H; Cao Y; Du M; Chen H
    BMC Cancer; 2020 Aug; 20(1):741. PubMed ID: 32770981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2.
    Xiu DH; Liu GF; Yu SN; Li LY; Zhao GQ; Liu L; Li XF
    J Exp Clin Cancer Res; 2019 Feb; 38(1):94. PubMed ID: 30791958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.